Brief: Heron Therapeutics Files For Resale Of Up To 21.9 Million Shares Of Common Stock - Sec Filing
Aug 23 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS INC FILES FOR RESALE OF UP TO 21.9
MILLION
SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING
Source text: [ID:https://bit.ly/3P7HkOx]
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop